Scilex Pharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for SCILEX PHARMS, and when can generic versions of SCILEX PHARMS drugs launch?
SCILEX PHARMS has two approved drugs.
There are ten US patents protecting SCILEX PHARMS drugs.
There are thirty-five patent family members on SCILEX PHARMS drugs in eighteen countries.
Drugs and US Patents for Scilex Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 10,765,749 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,931,403 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | 10,383,821 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,925,264 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scilex Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 122021017591 | ⤷ Try a Trial |
Mexico | 367430 | ⤷ Try a Trial |
European Patent Office | 2708229 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2017156392 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.